Carlson Capital L P Abbott Laboratories Transaction History

Carlson Capital L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $20.7 Million - $22.5 Million	-253,516 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $8.02 Million - $9.35 Million	110,016 Added 76.67%	253,516 $21.3 Million
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $9.25 Million - $11.2 Million	139,717 Added 3693.29%	143,500 $11.5 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $563,750 - $638,647	-8,599 Reduced 69.45%	3,783 $274,000
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $7.68 Million - $9.26 Million	-126,218 Reduced 91.07%	12,382 $908,000
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $7.98 Million - $8.81 Million	138,600 New	138,600 $8.45 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Carlson Capital L P, based on Form 13F filings with the SEC.

Stay updated on Carlson Capital L P with notifications on news.